M2I Life Sciences Funding: $75M Raised, Series C (2021)
M2I Life Sciences is based in Saint-Cloud, France. It has raised $75M in total funding. Latest round: Series C.
M2I Life Sciences funding overview
M2I Life Sciences is based in Saint-Cloud, France. M2I Life Sciences has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in June 2021. The round record for M2I Life Sciences runs through 2021; nothing later has been disclosed. Investors on record include Eurazeo Growth, ADM Capital, Tethys Invest, Creadev, Raise Impact, France 2i. 6 distinct backers are named across the disclosed rounds.
M2I Life Sciences has raised $75M in total disclosed funding across the rounds on record.
Who has invested in M2I Life Sciences?
Eurazeo Growth, ADM Capital, Tethys Invest, Creadev, Raise Impact, France 2i are named among the investors backing M2I Life Sciences.
What was the latest M2I Life Sciences funding round?
The most recent disclosed round is a Series C, announced in June 2021.
Where is M2I Life Sciences based?
M2I Life Sciences is based in Saint-Cloud, France.
When did M2I Life Sciences last raise?
The last disclosed M2I Life Sciences round closed in June 2021 at Series C.
We update the M2I Life Sciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Saint-Cloud and their backers are listed below.
